Literature DB >> 23498984

Diffusion-weighted MR imaging of focal liver lesions in the left and right lobes: is there a difference in ADC values?

Christine Schmid-Tannwald1, Yulei Jiang, Farid Dahi, Carsten Rist, Ila Sethi, Aytekin Oto.   

Abstract

RATIONALE AND
OBJECTIVES: To determine possible differences between the left and right hepatic lobes in apparent diffusion coefficient (ADC) values of benign and malignant focal liver lesions (FLLs) and normal liver parenchyma.
MATERIALS AND METHODS: Thirty-six patients (16 males, 20 females; mean age 56.8 years) with FLLs of the same etiology in both the left and right hepatic lobes (13 patients with 26 benign FLLs and 23 patients with 46 malignant FLLs) who underwent 1.5T magnetic resonance imaging (MRI) including diffusion-weighted MRI (b values: 0 and 800 seconds/mm) with respiratory gating and without cardiac gating were included in this Health Insurance Portability and Accountability Act-compliant and institutional review board-approved study. ADC values of normal liver parenchyma and FLLs in each hepatic lobe were calculated and compared by using Student's t-test and Wilcoxon signed-rank test, respectively.
RESULTS: The mean ADC values of normal liver parenchyma, benign FLLs, and malignant FLLs were significantly higher (P < .001, P = .003, and P = .005, respectively) in the left hepatic lobe (1.74 × 10(-3), 1.81 × 10(-3), and 1.48 × 10(-3) mm²/second, respectively) than in the right hepatic lobe (1.48 × 10(-3), 1.54 × 10(-3), and 1.24 × 10(-3) mm²/second, respectively).
CONCLUSION: ADC values of benign and malignant FLLs calculated from noncardiac-gated DW-MRI are significantly higher in the left hepatic lobe compared with the right hepatic lobe. This may be a limitation for characterization of FLLs based on ADC measurements.
Copyright © 2013 AUR. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23498984     DOI: 10.1016/j.acra.2012.10.012

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  7 in total

1.  Test-retest reliability of diffusion tensor imaging of the liver at 3.0 T.

Authors:  Rossano Girometti; Marta Maieron; Giovanni Lissandrello; Massimo Bazzocchi; Chiara Zuiani
Journal:  Radiol Med       Date:  2014-11-25       Impact factor: 3.469

2.  Intravoxel incoherent motion: application in differentiation of hepatocellular carcinoma and focal nodular hyperplasia.

Authors:  Ma Luo; Ling Zhang; Xin Hua Jiang; Wei Dong Zhang
Journal:  Diagn Interv Radiol       Date:  2017 Jul-Aug       Impact factor: 2.630

Review 3.  Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI.

Authors:  Julius Chapiro; MingDe Lin; Rafael Duran; Rüdiger E Schernthaner; Jean-François Geschwind
Journal:  Expert Rev Anticancer Ther       Date:  2014-11-05       Impact factor: 4.512

4.  Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis.

Authors:  Jie Chen; Mingpeng Wu; Rongbo Liu; Siyi Li; Ronghui Gao; Bin Song
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

5.  A Scoring System for Predicting Microvascular Invasion in Hepatocellular Carcinoma Based on Quantitative Functional MRI.

Authors:  Chien-Chang Liao; Yu-Fan Cheng; Chun-Yen Yu; Leung-Chit Leo Tsang; Chao-Long Chen; Hsien-Wen Hsu; Wan-Ching Chang; Wei-Xiong Lim; Yi-Hsuan Chuang; Po-Hsun Huang; Hsin-You Ou
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

6.  A data-driven statistical model that estimates measurement uncertainty improves interpretation of ADC reproducibility: a multi-site study of liver metastases.

Authors:  Ryan Pathak; Hossein Ragheb; Neil A Thacker; David M Morris; Houshang Amiri; Joost Kuijer; Nandita M deSouza; Arend Heerschap; Alan Jackson
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

7.  Intravoxel Incoherent Motion Diffusion-weighted Imaging: Evaluation of the Differentiation of Solid Hepatic Lesions.

Authors:  Ma Luo; Ling Zhang; Xin-Hua Jiang; Wei-Dong Zhang
Journal:  Transl Oncol       Date:  2017-09-08       Impact factor: 4.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.